Sermorelin test results: how often vials pass lab testing
Sermorelin has the smallest test record of the 14 peptides we track, and more of its recent samples failed than passed. Here are the numbers and why it has a prescription route most research peptides lack.
Of the last 48 Sermorelin samples with a result in Finnrick's public lab-testing database, 21 passed and 27 failed: 44 percent of Sermorelin test results were a pass. Another 3 came back incomplete and are left out. Finnrick has published 51 Sermorelin tests from 15 sellers since 20 Apr 2025.
Sermorelin is a GHRH fragment with the most legitimate regulatory history of any growth-hormone secretagogue in our library. It was FDA-approved as Geref in the 1990s for growth-hormone deficiency in children. The branded product was pulled from the US market in 2008 for commercial reasons, not safety, and sermorelin is now prescribed through compounding pharmacies.
The short version
- 44 percent of recent samples passed. 21 passed and 27 failed, of the last 48 with a result.
- The approved product, Geref, was discontinued in 2008. Sermorelin is now prescribed through compounding pharmacies, largely off-label.
- A pass is a narrow result. It covers identity, purity and fill for the vial that was tested. It does not cover endotoxin, sterility or the next batch.
- We do not name sellers. The numbers describe the market, not any one shop.
Sermorelin test results in numbers
| Measure | Sermorelin |
|---|---|
| Published tests | 51 |
| Sellers with at least one test | 15 |
| First and latest test | 20 Apr 2025 to 29 Oct 2026 |
| Recent results counted | 48 (3 incomplete left out) |
| Passed | 21 |
| Failed | 27 |
| Pass rate | 44% |
| Rank by pass rate | 11 of 14 on our peptide test results page |
Figures from Finnrick's public Sermorelin page, checked on 12 November 2026. They will change as new results come in.
What counts as a pass or a fail
These figures use Finnrick's "Purity focus" standard, the one its public pages show. A sample passes when its purity is at least 99.5 percent and the amount in the vial is within 35 percent of the label. A sample that turns out to be a different molecule fails under every standard Finnrick uses. Endotoxin testing is not required under this standard, so a pass says nothing about endotoxin or sterility.
The pass rate counts passes and fails among the most recent results on Finnrick's public page, up to 200, and leaves out tests that came back incomplete. Finnrick says it sources samples from sellers and sends them to third-party labs, with HPLC as the main method. Its methodology page has the detail.
Is sermorelin FDA-approved?
It was. Geref was approved in the 1990s and withdrawn in 2008 for commercial reasons (see our sermorelin page). Today sermorelin reaches patients through compounding pharmacies on a prescription, mostly off-label, rather than as an approved product on sale. A research-labelled vial is neither.
A small record, and more fails than passes
Of the last 48 sermorelin samples with a result, 21 passed and 27 failed. That is a small sample: Finnrick has published only 51 sermorelin tests from 15 sellers since 20 Apr 2025, the fewest of the 14 compounds on our peptide test results page. Treat the exact percentage as rough.
Fewer tests probably reflect where buyers get sermorelin. With a prescription route through compounding pharmacies, fewer people need a research vial.
Before you buy Sermorelin
Sermorelin has a prescription route through compounding pharmacies, which is the safer one: the pharmacy carries the sourcing and testing. Peptide AI's prescription route through licensed telehealth is coming soon.
Before any order, three checks come first: the steps in how to vet a peptide supplier, an independent result for your own lot (how to get peptides tested), and the legal picture in is it legal to buy peptides. Products sold as research use only are not FDA-approved drugs, and a passing test does not make one safe to use.
Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Early access is here.
Questions people ask
What percentage of Sermorelin fails lab testing?
In Finnrick's public test database, 27 of the last 48 Sermorelin samples with a result failed, which is 56 percent, and 21 passed. Tests that came back incomplete are left out.
Is Sermorelin FDA-approved?
The approved product, Geref, was discontinued in 2008. Sermorelin is now prescribed through compounding pharmacies, largely off-label.
Does a passing lab test mean Sermorelin is safe?
No. A pass means the sample matched its label on identity, purity and fill under one standard. It does not cover endotoxin, sterility, other vials, or whether Sermorelin is safe or does anything in people.
Can you get sermorelin on a prescription?
Yes. Since the branded product was withdrawn, sermorelin has been prescribed through compounding pharmacies, mostly off-label. That is a different product from a research-labelled vial.
Sources
- Methodology, Finnrick, accessed 12 November 2026
- Sermorelin product page and public test history, Finnrick, accessed 12 November 2026
